Topoisomerase II contributes to DNA secondary structure-mediated double-stranded breaks

Nucleic Acids Res. 2020 Jul 9;48(12):6654-6671. doi: 10.1093/nar/gkaa483.

Abstract

DNA double-stranded breaks (DSBs) trigger human genome instability, therefore identifying what factors contribute to DSB induction is critical for our understanding of human disease etiology. Using an unbiased, genome-wide approach, we found that genomic regions with the ability to form highly stable DNA secondary structures are enriched for endogenous DSBs in human cells. Human genomic regions predicted to form non-B-form DNA induced gross chromosomal rearrangements in yeast and displayed high indel frequency in human genomes. The extent of instability in both analyses is in concordance with the structure forming ability of these regions. We also observed an enrichment of DNA secondary structure-prone sites overlapping transcription start sites (TSSs) and CCCTC-binding factor (CTCF) binding sites, and uncovered an increase in DSBs at highly stable DNA secondary structure regions, in response to etoposide, an inhibitor of topoisomerase II (TOP2) re-ligation activity. Importantly, we found that TOP2 deficiency in both yeast and human leads to a significant reduction in DSBs at structure-prone loci, and that sites of TOP2 cleavage have a greater ability to form highly stable DNA secondary structures. This study reveals a direct role for TOP2 in generating secondary structure-mediated DNA fragility, advancing our understanding of mechanisms underlying human genome instability.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Binding Sites / genetics
  • CCCTC-Binding Factor / genetics
  • DNA / genetics
  • DNA / ultrastructure
  • DNA Breaks, Double-Stranded / drug effects*
  • DNA Repair / genetics
  • DNA Topoisomerases, Type II / genetics
  • DNA Topoisomerases, Type II / ultrastructure*
  • Etoposide / pharmacology
  • Genome, Human / genetics
  • Genomic Instability / genetics
  • Humans
  • Nucleic Acid Conformation / drug effects*
  • Transcription Initiation Site / drug effects

Substances

  • CCCTC-Binding Factor
  • Etoposide
  • DNA
  • DNA Topoisomerases, Type II